OakChart

IM Cannabis Corp

IMCCHealthcare·Drug Manufacturers - Specialty & Generic·Israel·Nano·NASD·Nov 11 • 1:41 PM ET

0.5916-0.0204 (-3.33%)
2026-11-11 19:57 CET
Market cap
1.01 USD m
Revenue, TTM
33.12 USD m
Net income, TTM
-12.94 USD m
Free cash flow, TTM
-1.64 USD m
EPS diluted, TTM
-62.81
P/E
-
Compare

Price

IMCC against its 20, 50 and 200-day averages
2050200
0.0010.0020.0030.0040.0052.5M105.0MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26IMCCclose 0.5920-day 0.9150-day 1.69200-day 9.560.59

99.1% under the 52-week high of 62.40 on 12 Dec 2025. 52-week low 0.56 on 11 Nov 2026. Last 15 sessions, 106.3% high to low

Profile

IMCC
52-week range, 0% of the way up
0.5862.40

IM Cannabis Corp. engages in the production and sale of medical cannabis products. It offers dry flower products and cannabis oil products under the IMC brand. The company was founded on March 7, 1980 and is headquartered in Glil Yam, Israel.

Employees44
IPOMay 20, 2020
Beta2.57
ATR, 14d0.19
Rel volume0.01
Short float1.35%
Insider own34.40%
Inst own0.63%

Snapshot

6 groups

Valuation

Index-
Market Cap0.98M
Enterprise Value9.44M
Income-12.94M
Sales33.12M
Book/sh-7.18
Cash/sh0.75
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees44
IPOMay 20, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S0.03
P/B-
P/C0.79
P/FCF-
EV/EBITDA-
EV/Sales0.28
Quick Ratio0.46
Current Ratio0.56
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-62.81
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y74.93% 43.53%
Sales past 3/5Y-2.09% 27.02%
EPS Y/Y TTM-285.26%
Sales Y/Y TTM-11.91%
EPS Q/Q-396.75%
Sales Q/Q-40.21%
EarningsAug 13 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own34.40%
Insider Trans0.00%
Inst Own0.63%
Inst Trans12.84%
ROA-54.47%
ROE-25089.74%
ROIC-
Gross Margin12.57%
Oper. Margin-25.87%
Profit Margin-39.06%
SMA20-34.83%
SMA50-65.01%
SMA200-93.81%
Trades-

Technical

Shs Outstand1.65M
Shs Float1.08M
Short Float1.35%
Short Ratio0.01
Short Interest0.01M
52W High62.40 -99.05%
52W Low0.58 1.91%
Volatility12.43% 13.32%
ATR (14)0.19
RSI (14)28.79
Beta2.57
Rel Volume0.01
Avg Volume2.69M
Volume20,172

Performance

Perf Week-17.47%
Perf Month-56.50%
Perf Quarter-84.83%
Perf Half Y-92.15%
Perf YTD-98.58%
Perf Year-98.66%
Perf 3Y-99.28%
Perf 5Y-99.99%
Perf 10Y-
Recom2.00
Target Price180.00
Prev Close0.61
Price0.59
Change %-3.33%

Analyst ratings

latest 2 of 2
DateActionAnalystRating changeTargetImplied
Oct 05, 2021InitiatedRROTH CapitalBuy$8+1,252.3%
Jul 14, 2021InitiatedDDesjardinsBuy

Peers

Mkt cap
TickerCompanyMkt cap
INCRIntercure Ltd51.23M
ACBAurora Cannabis Inc332.97M
TLRYTilray Brands Inc393.92M
CGCCanopy Growth Corp259.77M
OGIOrganigram Global Inc121.00M
CRONCronos Group Inc1.27B
AKANAkanda Corp1.95M
YCBDcbdMD Inc4.33M
IXHLIncannex Healthcare Inc25.96M
SNDLSNDL Inc341.87M

News

latest 14 of 200
  • IM Cannabis Raises US$1,200,000 of Gross Proceeds in Convertible Note Financing (PR Newswire) -17.22%
  • IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet (PR Newswire)
  • IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares (PR Newswire) +9.28% -10.69%
  • IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire) -29.71%
  • IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares (PR Newswire)
  • IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market (PR Newswire)
  • IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing (PR Newswire) -26.67%
  • IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis (PR Newswire) +17.89% -13.45%
  • IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance (PR Newswire)
  • IM Cannabis Agrees European Asset Sale as Transaction Targets C$3 Million Equity Improvement (InvestorsHub) -14.00%
  • IM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused Assets (PR Newswire)
  • IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results (PR Newswire) -6.08%
  • IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing (PR Newswire)
  • IM Cannabis Provides Corporate Update (PR Newswire) -11.17%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2025Q32025-11-13-16.059--55.1009.89--
2025Q22025-08-12-1.959--2.0539.22--
2024Q42025-03-31-6.669-11.280-7.0299.2410.091
2024Q32024-11-14-8.778-21.033-9.0869.9111.391
2024Q22024-08-14-5.040-25.791-29.75610.819.632
2024Q12024-05-08-55.101-26.604-56.0338.797.831
2023Q42024-03-28-33.246-22.140-32.4567.917.722
2023Q32023-11-13-20.862-28.044-21.5528.969.871
2023Q22023-08-14-34.758-10.152-35.1549.819.982
2023Q12023-05-153.996-34.5243.6379.7610.642
2022Q42023-03-29-553.82-34.902-578.38-5.3511.502
2022Q32022-11-14-2,455-104.56-2,49310.6819.722
2022Q22022-08-15-418.23-55.602-426.7418.4520.471
2022Q12022-05-13-236.34-21.618-195.318.2019.982
2021Q42022-03-31-273.82-56.250-269.8916.0114.412
2021Q32022-02-23-200.11--256.0811.45-2

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-307.37--309.356.466.19
2020FY-659.25--998.6512.8414.48
2021FY-951.12-486.22-44043.4741.01
2022FY-3,575-3,071-3,63739.9956.71
2023FY-98.430-80.967-98.81436.0638.35
2024FY-94.007-113.83-94.00737.5438.44
2025FY--9.519-57.325-54.29
2026FY--9.636--62.75

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2025Q4S2025-04-0210015.6615.6615.66
2025Q4S2025-04-0110015.6615.6615.66
2025Q4S2025-03-3110015.6615.6615.66
2025Q4S2025-03-3010015.6615.6615.66
2025Q4S2025-03-2910115.6615.6615.66
2025Q4S2025-03-2810115.6615.6615.66
2025Q4S2025-03-2710115.6615.6615.66
2025Q4S2025-03-2610115.6615.6615.66
2025Q4S2025-03-2510115.6615.6615.66
2025Q4S2025-03-2410115.6615.6615.66
2025Q4S2025-03-2310115.6615.6615.66
2025Q4S2025-03-2210115.6615.6615.66
2025Q4S2025-03-2110115.6615.6615.66
2025Q4S2025-03-2010115.6615.6615.66

Estimate history

EPS, annual-0.807-8.31-309.347-998.648-440.003-3636.927-98.814-98.669-57.325-62.812
Period201520162019202020212022202320242025TTM
EPS, quarterly-29.756-9.086-7.0291.864-2.053-16.352-27.863-8.399-10.198
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual006.83911.84727.16141.73736.15939.4439.16933.12
Period201520162019202020212022202320242025TTM
Sales, quarterly10.78210.1789.5368.7129.16810.05811.2486.3275.482
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.0430.0010.020.0220.0380.0420.0740.1030.1960.543
Period201520162019202020212022202320242025MRQ
Shares, quarterly0.0740.0740.1030.1030.1350.1750.1960.2070.543
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue33.1239.1739.4436.1641.7427.1611.856.84
Cost of Goods Sold Incl. D&A28.9533.6334.8631.0834.4627.1412.838.39
Gross Profit4.165.544.585.087.280.02-0.98-1.55
Selling, General and Administrative Excl. Other10.509.269.6914.1027.3223.4213.957.97
Research and Development------0.100.18
Other Operating Expense2.230.000.000.000.000.000.000.00
Operating Income-8.57-3.72-5.11-9.02-20.04-23.40-14.93-9.52
Interest Expense3.832.513.262.721.510.5418.170.53
Unusual Expense0.000.00-0.150.463.61-5.03-11.67-4.53
Net Income Before Taxes-13.37-8.34-9.34-7.01-20.02-0.13-21.23-5.52
Income Taxes0.040.07-0.750.57-0.870.400.200.07
Consolidated Net Income-13.41-8.41-8.59-7.58-19.14-0.53-21.42-5.59
Net Income From Continuing Operations-12.94-8.10-7.73-7.04-17.290.07-21.40-5.50
Net Income-12.94-8.10-7.73-7.04-145.09-14.17-21.40-5.50
EPS (Recurring)-41.88-57.33-99.97-94.32-3,573.61-549.38-1,379.96-487.83
EPS (Basic, Before Extraordinaries)-62.81-57.33-98.67-98.81-3,636.93-440.00-998.65-309.35
EPS (Diluted)-62.81-57.33-98.67-98.81-3,636.93-440.00-998.65-309.35
EBITDA-7.07-2.32-3.52-6.80-14.41-18.83-14.24-9.07
Non-Operating Income (Expense)-3.18-2.12-1.115.195.1518.780.210.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-0.010.190.121.493.181.851.48
Price To Sales Ratio0.050.150.140.130.177.1325.39-
Gross Margin12.5714.1411.6114.0517.440.07-8.26-22.71
Operating Margin-25.87-9.50-12.96-24.95-48.02-86.17-126.03-139.22
Net Margin-39.06-20.68-19.59-19.46-347.64-52.16-180.60-80.36
Shares Outstanding0.540.200.100.070.040.040.020.02
Market Capitalization1.011.017.194.787.27227.85223.02-

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue5.486.3311.2510.069.178.719.5410.18
Cost of Goods Sold Incl. D&A4.395.2911.198.076.706.317.627.87
Gross Profit1.091.030.061.982.472.401.922.31
Selling, General and Administrative Excl. Other2.602.262.882.772.732.292.123.01
Other Operating Expense0.000.000.002.230.000.000.000.00
Operating Income-1.51-1.22-2.82-3.02-0.250.11-0.21-0.70
Interest Expense2.110.610.620.501.270.010.500.11
Unusual Expense0.000.000.000.000.000.00-0.160.00
Net Income Before Taxes-3.20-1.83-5.64-2.70-0.160.10-0.90-0.81
Income Taxes-0.03-0.030.000.10-0.02-0.02-0.03-0.02
Consolidated Net Income-3.17-1.80-5.64-2.81-0.140.12-0.87-0.79
Net Income From Continuing Operations-3.15-1.66-5.47-2.65-0.220.19-0.72-0.68
Net Income-3.15-1.66-5.47-2.65-0.220.19-0.72-0.68
EPS (Recurring)-10.20-8.40-27.86-16.35-2.051.86-8.12-9.06
EPS (Basic, Before Extraordinaries)-10.20-8.40-27.86-16.35-2.051.86-7.03-9.09
EPS (Diluted)-10.20-8.40-27.86-16.35-2.051.86-7.03-9.09
EBITDA-1.11-0.86-2.45-2.650.090.430.18-0.37
Non-Operating Income (Expense)0.420.00-4.400.811.360.00-0.350.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.000.00-0.000.000.000.000.13
Price To Sales Ratio0.050.060.210.250.220.120.180.14
Gross Margin19.8316.350.5219.7226.9827.5820.1022.68
Operating Margin-27.54-19.31-25.06-29.98-2.761.26-2.15-6.86
Net Margin-57.46-26.24-48.67-26.36-2.432.20-7.58-6.64
Shares Outstanding0.540.210.200.170.130.100.100.07
Market Capitalization1.012.308.1910.0710.034.667.195.31

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2016FY
Cash & Short Term Investments2.410.641.371.8111.016.9910.74-0.00
Short Term Receivables9.4711.608.597.7624.694.491.59-0.00
Inventories4.633.878.2813.4426.429.466.20-0.00
Other Current Assets0.080.130.161.102.150.370.21-0.00
Total Current Assets16.5916.2518.4024.1164.2721.3118.73-0.00
Net Property, Plant & Equipment3.002.914.835.2838.345.083.40-0.00
Total Investments and Advances1.301.131.731.781.931.840.70-0.00
Intangible Assets2.276.9612.0613.05122.961.100.92-0.00
Deferred Tax Assets--0.000.560.010.600.07--
Other Assets0.000.000.000.000.000.000.00-0.00
Total Assets23.1527.2537.0244.78227.5229.9223.82-0.00
Short Term Debt Incl. Current Port. of LT Debt11.1412.089.547.428.750.130.12-0.00
Accounts Payable8.797.766.9911.3011.072.040.76-0.00
Other Current Liabilities4.874.448.356.2320.732.741.12-0.31
Total Current Liabilities24.8124.2824.8824.9640.554.922.01-0.32
Long Term Debt0.720.440.921.0914.420.650.69-0.00
Provision for Risks Charges0.000.000.070.180.310.290.20-0.00
Deferred Tax Liabilities0.260.340.730.985.221.180.64--
Other Liabilities0.000.000.030.014.7712.980.15-0.00
Total Liabilities25.7925.0626.6327.2265.2720.023.69-0.32
Non-Equity Reserves0.000.000.000.000.000.000.00-0.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00-0.00
Common Equity-2.723.6510.9716.72159.318.7119.02-8.32
Total Shareholders Equity-2.723.6510.9716.72159.318.7119.02-8.32
Accumulated Minority Interest0.08-1.46-0.580.852.941.191.12--8.64
Total Equity-2.642.1910.3917.56162.259.9020.13--0.32
Total Liabilities & Stockholders Equity23.1527.2537.0244.78227.5229.9223.82-0.00
Book Value Per Share-13.8535.45147.46397.554,209.91394.27939.47-5,799.15
Tangible Book Value Per Share-25.38-32.24-14.5687.24960.64344.68894.24-5,799.15
Full-Time Employees44559515336379---
Price to Book Ratio-0.091.970.340.181.431.35---
Return on Assets-32.15-24.05-17.21-12.700.06-79.62---5,665.39
Return on Equity-1,752.65-105.71-50.83-19.650.09-154.33---0.14
Return on Invested Capital--188.98-59.19-814.86-8.16-228.67-27.89--0.14
Quick Ratio0.480.510.410.430.932.416.23-0.00
Current Ratio0.670.670.740.971.584.339.31-0.00

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-13.36-8.41-8.59-7.58-146.95-14.77-21.42-5.59
Depreciation1.491.401.592.225.634.570.690.45
Other Funds (Non Cash)6.233.092.92-3.19106.74-9.0415.962.71
Funds from Operations-5.77-4.04-4.18-8.26-36.88-19.02-4.82-2.50
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital4.145.611.881.0426.48-8.61-1.09-1.99
Cash from Operating Activities-1.631.57-2.30-7.22-10.40-27.62-5.90-4.49
Capital Expenditures-0.01-0.01-0.11-0.43-1.20-3.67-2.02-1.17
Net Assets From Acquisitions0.000.000.000.000.00-10.000.00-0.99
Sale of Fixed Assets and Businesses0.000.000.070.000.160.000.000.00
Purchase or Sale of Investments0.000.000.00-0.450.000.24-1.00-0.69
Purchase of Investments0.000.000.00-0.450.00-0.01-1.00-0.69
Sale Or Maturity of Investments0.000.000.000.000.000.250.000.00
Other Uses0.000.00-0.250.00-0.310.000.000.00
Other Sources0.000.000.000.000.276.220.000.00
Cash from Investing Activities-0.01-0.01-0.30-0.88-1.08-7.20-3.02-2.84
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock4.253.621.506.133.1434.435.2113.69
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock4.253.621.506.133.1434.435.2113.69
Proceedsfrom Stock Options3.633.620.691.252.8922.440.0011.73
Issuance or Reduction of Debt, Net0.001.05-0.890.000.000.000.00-0.72
Change in Long Term Debt0.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-4.21-1.813.982.563.586.220.000.00
Other Financing Activities Uses-4.21-1.810.00-3.58-3.820.000.000.00
Cash from Financing Activities3.822.624.318.214.3539.085.0212.85
Exchange Rate Effect-1.54-2.48-2.36-0.59-1.67-0.260.16-0.74
Net Change in Cash0.641.70-0.65-0.47-8.803.99-3.744.77
Free Cash Flow-1.641.56-2.42-7.65-11.60-31.28-7.86-5.66
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Price to Free Cash Flow-3.77------
Deferred Taxes & Investment Tax Credit--0.12-0.110.29-2.310.22-0.05-0.07

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments1.230.832.411.660.611.01
Short Term Receivables4.835.149.478.099.1711.57
Inventories2.011.434.637.202.683.77
Other Current Assets3.423.440.085.806.184.16
Total Current Assets11.4910.8316.5922.7618.6420.51
Net Property, Plant & Equipment2.742.823.003.113.132.96
Total Investments and Advances1.391.301.301.251.231.11
Intangible Assets1.782.032.274.747.106.64
Other Assets0.000.000.000.000.000.00
Total Assets17.4016.9823.1531.8630.1031.22
Short Term Debt Incl. Current Port. of LT Debt9.2710.1411.1411.7810.4210.61
Accounts Payable5.975.888.795.148.9211.14
Other Current Liabilities5.463.854.8710.726.426.60
Total Current Liabilities20.7019.8624.8127.6425.7628.34
Long Term Debt0.480.580.720.841.050.36
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.200.210.260.290.320.31
Other Liabilities0.000.000.000.000.000.00
Total Liabilities21.3720.6525.7928.7727.1229.02
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-3.90-3.62-2.722.852.583.70
Total Shareholders Equity-3.90-3.62-2.722.852.583.70
Accumulated Minority Interest-0.06-0.050.080.240.40-1.49
Total Equity-3.97-3.67-2.643.092.982.20
Total Liabilities & Stockholders Equity17.4016.9823.1531.8630.1031.22
Book Value Per Share-7.18-17.45-13.8516.2919.1435.97
Tangible Book Value Per Share-10.47-27.24-25.38-10.80-33.51-28.56
Full-Time Employees--44---
Price to Book Ratio-0.09-0.64-3.013.543.891.26
Return on Assets-54.47-41.53-32.37-10.49-4.81-11.11
Return on Equity--25,089.74-1,764.96-93.88-36.93-63.75
Return on Invested Capital----71.87-6.154.73
Quick Ratio0.460.470.480.560.620.59
Current Ratio0.560.550.670.820.720.72

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-3.15-1.80-5.61-2.81-0.140.12
Depreciation0.400.360.360.370.350.32
Other Funds (Non Cash)2.300.062.401.47-0.13-0.65
Funds from Operations-0.49-1.40-2.89-0.990.06-0.23
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.441.115.52-2.05-0.512.66
Cash from Operating Activities-0.93-0.292.64-3.04-0.452.43
Capital Expenditures-0.00-0.00-0.00-0.00-0.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.00-0.00-0.00-0.00-0.000.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.620.00-0.043.680.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.620.00-0.043.680.000.00
Proceedsfrom Stock Options0.000.00-0.043.680.000.00
Issuance or Reduction of Debt, Net0.761.83-0.451.910.00-0.41
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.74-2.29-0.62-0.570.22-0.85
Other Financing Activities Uses-0.74-2.29-0.62-0.570.22-0.85
Cash from Financing Activities0.57-0.52-1.164.940.18-1.32
Exchange Rate Effect0.79-0.75-0.77-0.81-0.16-0.74
Net Change in Cash0.44-1.570.701.08-0.430.37
Free Cash Flow-0.93-0.302.63-3.05-0.452.43
Price to Free Cash Flow--5.24-53.995.43

Revenue breakdown

Cannabis Products2024: 37.48M 2025: 38.06M
Other Cannabis2024: 1.97M 2025: 1.11M
Country of domicile2024: 28.13M 2025: 13.15M
Foreign countries2024: 11.32M 2025: 26.01M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.35%0.0M1.1M2.69M
2026-10-153.34%0.0M1.1M2.71M
2026-09-3053.33%0.1M0.1M2.74M
2026-09-158.26%0.0M0.6M160.92K
2026-08-3113.93%0.0M0.1M201.04K
2026-08-1416.10%0.0M0.1M177.01K
2026-07-3123.72%0.0M0.1M174.39K
2026-07-1510.70%0.0M0.1M141.61K
2026-06-3018.67%0.0M0.1M142.45K
2026-06-157.17%0.0M0.1M76.64K
2026-05-295.14%0.0M0.1M22.37K
2026-05-151.38%0.0M0.1M17.41K
2026-04-302.28%0.0M0.1M16.36K
2026-04-153.04%0.0M0.1M9.44K
2026-03-313.52%0.0M0.1M8.83K
2026-03-130.44%0.0M0.1M3.61K
2026-02-270.50%0.0M0.1M4.84K
2026-02-131.12%0.0M0.1M5.49K
2026-01-301.81%0.0M0.1M5.61K
2026-01-153.58%0.0M0.1M18.39K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10F-3Registration statement for specified transactions by certain foreign private issuersSEC
2026-11-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-04SEC
2026-10-20EFFECTEffectiveness filing by commission orderSEC
2026-10-08F-3Registration statement for specified transactions by certain foreign private issuersSEC
2026-10-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-02SEC
2026-09-30SCHEDULE 13GSEC
2026-09-30SCHEDULE 13GSEC
2026-09-30SCHEDULE 13GSEC
2026-09-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-28SEC
2026-09-256-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-25SEC
2026-09-24424B5SEC
2026-09-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-24SEC
2026-09-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-23SEC
2026-09-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-23SEC
2026-09-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-02SEC
2026-08-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-27SEC
2026-08-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-18SEC
2026-08-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-17SEC
2026-08-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-30SEC
2026-08-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-06SEC
2026-07-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-27SEC
2026-07-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-01SEC
2026-06-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-18SEC
2026-06-16EFFECTEffectiveness filing by commission orderSEC
2026-06-15CORRESPSEC
2026-06-12UPLOADUpload SubmissionSEC
2026-06-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-09SEC
2026-06-09F-3Registration statement for specified transactions by certain foreign private issuersSEC
2026-06-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-03SEC
2026-05-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-13SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
HRT FINANCIAL LP7.14%
CITADEL ADVISORS LLC1.64%
JANE STREET GROUP, LLC1.23%
StoneX Group Inc.0.75%
Hidden Cove Wealth Management, LLC0.46%
BANK OF MONTREAL /CAN/0.39%
Federation des caisses Desjardins du Quebec0.06%
NATIONAL BANK OF CANADA /FI/0.00%
ROYAL BANK OF CANADA0.00%
OSAIC HOLDINGS, INC.0.00%

Funds

Fund% owned
-

OakChart. IMCC. Cached 15 minutes.

Some panels did not load: insider.